Crowdonomics
Nannocare

Reg CF · Common Stock · Sep 2019

ClosedReached targetReg CFCommon Equity
via StartEngine · last checked Oct 4, 2026View campaign
Raised
$45.1K / $107K max
42% of ceiling · target hit day 14
Investors
88
$521.9 avg
Post-money valuation
$14.8M
pre-money + amount raised

Raised over time

Cumulative raisedInvestors
$47K$24K$0
90450
Sep 17, 2019 · openedDec 18, 2019 · last reading
Target ($10K) hit — Oct 1, 2019, day 14Deadline Dec 17, 2019

Left axis: cumulative dollars raised. Right axis: cumulative investors. Live figures via StartEngine, last checked Oct 4, 2026; investor counts may lag the platform by up to a day.

Financials disclosed in this offering

FY2017–FY2018 · hover for source
$0
−$50K
FY2017
$48K
−$389K
FY2018
RevenueNet income
Metric
FY2017 unaudited*
FY2018 unaudited*
Income statement
Revenue
$0
$47,581
Cost of goods sold
$17,524
$1,601
Gross margin
—
97%
Net income
-$49,984
-$389,115
Taxes paid
$0
$0
Balance sheet
Cash
$50,016
$36,043
Accounts receivable
$0
$28,131
Total assets
$50,016
$153,297
Short-term debt
$0
$64,566
Long-term debt
$0
$151,580
Total liabilities
$0
$216,146
Other
Headcount
—
8

The fiscal years the issuer disclosed in this offering’s filing, as filed. Full history on the company page.

Deal terms

Pre-money$14.8M
Post-money$14.8M
Price / share$2.47
Shares offered4,048

Perks

10% bonus share · until Oct 6, 201910% bonus

Offering details

Target$9,999
Max$106,998
Min investment$247
OpenedSep 17, 2019
DeadlineDec 17, 2019
ClosedDec 17, 2019
Days active91

Links & provenance

Source: SEC EDGAR
0001665160-19-000938
Last synced Sep 6, 2026

About this data. Raised amounts and investor counts come from the platform listing and may lag or be restated; SEC-reported totals can differ until the next Form 1-Z/C-U. Post-money valuation is computed as pre-money plus amount raised and is shown once the round closes — it is not a traded price. Financial statements are as reported by the issuer. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.